To err is human, to correctly formulate is divine: Risky assumptions for addressing limited bioavailability


Finding a safe and effective compound to bring to market is challenging and costly enough – avoid risking additional expense, be it time or money, by not making these assumptions about the importance of a well planned and executed formulation development strategy.